Perioperative Management Evaluation in Patients With CIED

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKlinikum-Fuerth

About this trial

Background: Recommendations for peri-operative management in patients with implanted cardiac electronic devices (CIED) are often based on older data from case reports and small collectives.

Objective: To evaluate the peri-operative management and outcome of patients with implanted CIED undergoing non-CIED related surgery or catheter-interventional procedures in clinical routine.

Study design: bi-center, non-randomized, observational registry, retrospective data-collection, on-going prospective patient enrollment, descriptive statistics

Primary endpoint: number and type of peri-operative adverse device related events (ADE) Secondary endpoints: pre-interventional data (patient characteristics, data from CIED interrogation); peri-interventional data (type of surgery/intervention, anesthesiology techniques, any AE), postinterventional data (data from post-interventional CIED interrogation, need for reprogramming / device revision).

Inclusion criteria: implanted CIED, non-CIED related surgical or catheter-based intervention, peri-procedural CIED interrogation, age \>18 years Exclusion criteria: no implanted CIED, no data from any peri-procedural CIED interrogation available

Patient enrollment: retrospectively beginning from 2008, further on-going prospective inclusion Sample size: For the observational study, there is no pre-specified sample size. Data from more than 500 patients undergoing \> 700 interventions are expected.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

implanted CIED (e.g. pacemaker, ICD, CRT),

performed (non-CIED related) surgical or catheter-based procedure,

data from peri-procedural CIED interrogation available

age >18 years

Disqualifiers

no implanted CIED,

no data from any peri-interventional CIED interrogation available

Trial population

Enrollment of all consecutive patients according to the inclusion criteria, undergoing surgery or catheter-ablation at the Klinikum Fuerth or Klinikum Nueremberg. Data collection will be * retrospectively beginning from 2008, * on-going with further prospective data collection and patient enrollment. If possible, patients will be enrolled at pre-interventional device interrogation. If there is no pre-interventional device interrogation (e.g. in case of urgent or emergency surgery), patients will be enrolled retrospectively.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • surgery or catheter based cardiac procedure (catheter ablation)

    Procedure/Surgery

    patients with implanted CIED (pacemaker, ICD or CRT) that undergo any surgery or any catheter based cardiac procedure (e.g. radiofrequency ablation)

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

surgery or catheter-based procedure related (S)ADE

any (S)ADE related to the surgical or catheter-based procedure

Time frame
1 month post-procedural

Secondary outcomes

1

device: post-procedural pacing threshold increase

post-procedural pacing threshold increase \> 50% compared with the pre-procedural threshold (given a safety margin of 100%)

Time frame
1 month post-procedural
2

device: post-procedural sensing decrease

post-procedural sensing decrease by \> 50% compared with the pre-procedural sensing

Time frame
1 month post-procedural
3

device: post-procedural lead impedance

post-procedural lead impedance is different by \> 25% compared with the pre-procedural impedance

Time frame
1 month post-procedural

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Klinikum-Fuerth

Lead sponsor

Klinikum Nürnberg

Collaborator